Newsletter Tool

Featured Story

Pfizer plans to seek FDA nod for COVID-19 shot in kids 5 to 11 after positive data

By Kevin Dunleavy

Pfizer and BioNTech reported that their COVID-19 vaccine is safe and generated a strong response in kids aged 5 to 11. The smaller dosage shot (10 micrograms) provided comparable antibody responses the the 30 microgram dose given to 16- to 25-year-olds. The companies will apply for EUA "as soon as possible."

SPAC Attack: The 10 biggest in healthcare

By Heather Landi

Spurred by the COVID-19 pandemic and the virtual care boom, special purpose acquisition companies have been on a red-hot streak, triggering a whirlwind of public exit activity for healthcare and digital health startups.

Abbott joins TAVR market with FDA approval for its Portico heart valve

By Conor Hale

Previously available in Europe, the Portico valve is designed for severely narrowed aortic heart valves and is for use in patients where open-heart surgery may be too risky.

Ventyx Biosciences snags $51M, hires new CMO from Horizon Therapeutics

By Kyle LaHucik

Ventyx Biosciences is the amalgamation of three biotechs, and now it's bringing together three autoimmune experts and another $51 million to back their work.

Feds charge 138 medical professionals with $1.4B in healthcare fraud, including telehealth schemes

By Heather Landi

The Department of Justice on Friday announced criminal charges against 42 doctors and nurses and nearly 100 other medical professionals for alleged healthcare fraud schemes that cost $1.4 billion in losses.

Good ad or bad ad? FDA quiz reminds docs about its Bad Ad program to police problematic advertising

By Beth Snyder Bulik

True or False: Pharmaceutical companies are required to send drug ads to FDA for approval before they're used. It’s false—but you'd already would know that if you took the FDA’s new interactive quiz to help promote its Bad Ad program.

ESMO: Syros targets KRAS-mutant cancer as CDK7 inhibitor shows early promise

By Angus Liu

Syros’ oral CDK7 inhibitor showed robust antitumor activity in mouse models of KRAS-mutant pancreatic cancer and non-small cell lung cancer. The biotech is now expanding its ongoing phase 1 trial based on the finding.

CDC announces $2.1B investment into infection control, surveillance across healthcare settings

By Dave Muoio

The money will cover initiatives at public health agencies and provider facilities ranging from COVID-19 strike teams to antibiotic stewardship programs. The agency will begin awarding the first wave of funds in October.

Medtronic recalls brain aneurysm-blocking implant due to potential breakages during placement

By Andrea Park

Two deaths have been linked to the recall so far, according to the FDA, in addition to 10 serious injuries and another 59 reports of device malfunctions.

COVID-19 tracker: CDC finds Moderna shot to be most effective at preventing hospitalizations

By Noah Higgins-Dunn,Kevin Dunleavy,Fraiser Kansteiner

A nationwide study by the CDC found the Moderna vaccine to be most effective in preventing COVID-19 hospitalizations. Plus more.

PM Tracker